Dernières publications scientifiques

  • Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials.

  • Auteurs Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Schönenberger CM, Schobinger S, Agoritsas T, Tomashek KM, Nayak S, Makowski M, Morales-Ortega A, Bernal-Bello D, Pomponio G, Ferrarini A, Ghazaeian M, Hall F, Bond S, García-Morales MT, Jiménez-González M, Arribas JR, Guimaraães PO, Tavares CAM, Berwanger O, Yazdanpanah Y, Simensen VC, Lacombe K, Hites M, Ader F, Tacconelli E, Mentré F, Belhadi D, Massonnaud CR, Laouénan C, Diallo A, Baldé A, Assoumou L, Costagliola D, Ponzi E, Rueegg CS, Olsen IC, Trøseid M, Briel M
  • Revue Lancet Respir Med
  • Date de publication 2025-05
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials.
  • Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study.

  • Auteurs de Jong VD, Alings M, Bruha R, Cortez-Pinto H, Dedoussis GV, Doukas M, Francque S, Fournier-Poizat C, Gastaldelli A, Hankemeier T, Holleboom AG, Miele L, Moreno C, Muris JWM, Ratziu V, Romero-Gomez M, Schattenberg JM, Serfaty L, Stefan DC, Tushuizen ME, Verheij J, Willemse J, Franco OH, Grobbee DE, Castro Cabezas M
  • Revue BMJ Open
  • Date de publication 2025-05
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study.
  • Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.

  • Auteurs Collet L, Ardin M, Venet D, Berthet J, Ghamry-Barrin S, Treilleux I, Noel JC, Leheurteur M, Meunier J, Bengrine Lefevre L, Martinez M, Priou F, Selle F, Just PA, Bataillon G, Rothé F, Sotiriou C, Caux C, Dubois B, Ray-Coquard I, Le Saux O
  • Revue Clin Cancer Res
  • Date de publication 2025-05
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola